Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil

Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil

Sarcopenia is common in metastatic colorectal cancer (mCRC), increases the risk of treatment-related toxicity and reduces survival. Trifluridine/tipiracil (TT) chemotherapy significantly improved survival in refractory mCRC patients, but the prognostic and predictive role of pretherapeutic sarcopeni...

Full description

Bibliographic Details
Main Authors: Mateusz Malik, Maciej Michalak, Barbara Radecka, Marek Gełej, Aleksandra Jackowska, Emilia Filipczyk-Cisarż, Katarzyna Hetman, Małgorzata Foszczyńska-Kłoda, Beata Kania-Zembaczyńska, Danuta Mańka, Marlena Orlikowska, Hanna Rogowska-Droś, Lubomir Bodnar
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Journal of Clinical Medicine
Subjects:
sarcopenia
metastatic colorectal cancer
cancer cachexia
trifluridine/tipiracil
Online Access:https://www.mdpi.com/2077-0383/10/21/5107

Internet

https://www.mdpi.com/2077-0383/10/21/5107

Similar Items